We found that CypA, TDP-43 and ERp57 levels significantly differed in ALS>24 and ALS≤24 patients (Figure 3, Table 2), indicating that these proteins can discriminate between patients with high and low disease severity. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.